Jundishapur Journal of Microbiology

Published by: Kowsar

Dissemination of Extended-Spectrum β-Lactamases and Quinolone Resistance Genes Among Clinical Isolates of Uropathogenic Escherichia coli in Children

Iraj Sedighi 1 , Mohammad Reza Arabestani 2 , 3 , Ali Rahimbakhsh 4 , Zahra Karimitabar 2 and Mohammad Yousef Alikhani 2 , 3 , *
Authors Information
1 Department of Pediatric, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
3 Brucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, IR Iran
4 Department of Microbiology, Faculty of Basic and Medical Sciences, Islamic Azad University of Zanjan, Zanjan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 01, 2015, 8 (7); e19184
  • Published Online: July 25, 2015
  • Article Type: Research Article
  • Received: March 30, 2014
  • Revised: July 23, 2014
  • Accepted: July 26, 2014
  • DOI: 10.5812/jjm.19184v2

To Cite: Sedighi I, Arabestani M R, Rahimbakhsh A, Karimitabar Z, Alikhani M Y. Dissemination of Extended-Spectrum β-Lactamases and Quinolone Resistance Genes Among Clinical Isolates of Uropathogenic Escherichia coli in Children, Jundishapur J Microbiol. 2015 ; 8(7):e19184. doi: 10.5812/jjm.19184v2.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Murray PR, Baron EJ, Jorgensen J. H. , Landry ML, Michael A, Pfaller MA. Manual of Clinical Microbiology. 2007;
  • 2. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol. 2008; 46(2): 480-7[DOI][PubMed]
  • 3. White B. Diagnosis and treatment of urinary tract infections in children. Am Fam Physician. 2011; 83(4): 409-15[PubMed]
  • 4. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003; 47(7): 2242-8[PubMed]
  • 5. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004; 48(4): 1295-9[PubMed]
  • 6. Jeong JY, Yoon HJ, Kim ES, Lee Y, Choi SH, Kim NJ, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother. 2005; 49(6): 2522-4
  • 7. Schleiss MR. Nelson text book of pediatrics. 2011; [DOI]
  • 8. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105): 797-9[DOI][PubMed]
  • 9. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10): 629-40[DOI][PubMed]
  • 10. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4): 664-89[DOI][PubMed]
  • 11. Khodursky AB, Zechiedrich EL, Cozzarelli NR. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A. 1995; 92(25): 11801-5[PubMed]
  • 12. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005; 49(1): 118-25[DOI][PubMed]
  • 13. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 14. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. 2007;
  • 15. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009; 53(2): 639-45[DOI][PubMed]
  • 16. Chroma M, Kolar M. Genetic methods for detection of antibiotic resistance: focus on extended-spectrum beta-lactamases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(4): 289-96[PubMed]
  • 17. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007; 60(2): 394-7[DOI][PubMed]
  • 18. Datta P, Thakur A, Mishra B, Gupta V. Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India. Jpn J Infect Dis. 2004; 57(4): 146-9[PubMed]
  • 19. Daoud Z, Hakime N. [Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon]. Rev Esp Quimioter. 2003; 16(2): 233-8[PubMed]
  • 20. Shayanfar N, Rezaei M, Ahmadi M, Ehsanipour F. Evaluation of extended spectrum beta-lactamase (ESBL) positive strains of Klebsiella pneumoniae and Escherichia coli in bacterial cultures. Iran J Pathol. 2010; 5: 34-9
  • 21. Franiczek R, Dolna I, Krzyzanowska B, Szufnarowski K, Kowalska-Krochmal B. Conjugative transfer of multiresistance plasmids from ESBL-positive Escherichia coli and Klebsiella spp. clinical isolates to Escherichia coli strain K12 C600. Adv Clin Exp Med. 2007; 16(2): 239-47
  • 22. Bali E, Acik, L. , Sultan, N. . Phenotypic and molecular characterization of SHV, TEM and CTX-M and extended spectrum beta -lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res. 2010; 4(8): 650-4
  • 23. Sorlozano A, Gutierrez J, Fernandez F, Soto MJ, Piedrola G. A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain). Ann Microbiol. 2004; 54(2): 99-104
  • 24. Park Y, Kang HK, Bae IK, Kim J, Kim JS, Uh Y, et al. Prevalence of the extended-spectrum beta-lactamase and qnr genes in clinical isolates of Escherichia coli. Korean J Lab Med. 2009; 29(3): 218-23[DOI][PubMed]
  • 25. Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis. 2011; 64(3): 249-52[PubMed]
  • 26. Yazdi M, Nazemi A, Miri Nargesi MS, Khatami Nejad MR. Prevallence of SHV/CTX-M/TEM beta lactamase resistance genes in Escherichia coli isolated from UTI in Tehran city. Iran J Pathol. 2010; 4: 48-54
  • 27. Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonca R, Nonhoff C, Struelens MJ. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2006; 57(4): 771-4[DOI][PubMed]
  • 28. Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, Kayser Y, et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One. 2009; 4(6)[DOI][PubMed]
  • 29. Padmini B, Appalaraju SB. Extended spectrum beta lactamases in urinary isolates of Escherichia coli and Klebsiella pneumonia - prevalence and susceptibility pattern in a tertiary care hospital. Ind J Med Microbiol. 2004; 22(3): 172-4
  • 30. Oktem IM, Gulay Z, Bicmen M, Gur D, Hitit Project Study Group. . qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis. 2008; 61(1): 13-7[PubMed]
  • 31. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. J Infect Dev Ctries. 2010; 4(12): 779-803[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments